LOS ANGELES>—Aspirin may be an effective pretreatment for exercise in patients with multiple sclerosis (MS), according to a study described at...
A subset of MS patients with inflammatory relapse showed less risk of progression with disease-modifying therapy.
NASHVILLE—What guides decisions to start, stop, switch, or restart disease-modifying therapy (DMT) in patients with multiple sclerosis (MS)—...
The prodrome of multiple sclerosis (MS) may include an increased risk of nervous system, sensory, and musculoskeletal disorders, according to...
NASHVILLE—Multiple sclerosis (MS) traditionally has been considered a chronic inflammatory autoimmune disease, but inflammation decreases as the...
NASHVILLE—Two doses of ozanimod provide greater benefits on annualized relapse rate and MRI end points than interferon beta-1a...
NASHVILLE—Gadolinium-based contrast agents (GBCAs) are necessary for the accurate initial diagnosis of patients experiencing a...
LOS ANGELES—Eating fish at least once per week or eating fish one to three times per month, in addition to taking daily fish oil...
NASHVILLE—For patients with multiple sclerosis (MS) and walking impairments, high-intensity interval exercise is as enjoyable as...
NASHVILLE—For patients with multiple sclerosis (MS) who receive treatment with natalizumab, progressive multifocal...
At the 2018 CMSC Annual Meeting, Dr. DeLuca discusses the role of cognitive rehabilitation in MS.
NASHVILLE—Among veterans with multiple sclerosis (MS), excess MS-related mortality is mainly influenced...
NASHVILLE—Treatment with cladribine tablets 3.5 mg/kg reduces MRI markers of disease activity in patients with highly active...
NASHVILLE—In patients with pediatric-onset multiple sclerosis (MS), fingolimod significantly reduces MRI activity and slows brain volume loss for...
